Skip to main content

Published locations for 1 in 15 patients who start dupilumab may develop conjunctivitis, large analysis finds

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. 1 in 15 patients who start dupilumab may develop conjunctivitis, large analysis finds

User login

  • Reset your password
  • /content/1-15-patients-who-start-dupilumab-may-develop-conjunctivitis-large-analysis-finds
  • /edermatologynews/article/241779/atopic-dermatitis/1-15-patients-who-start-dupilumab-may-develop
  • /familypracticenews/article/241779/atopic-dermatitis/1-15-patients-who-start-dupilumab-may-develop
  • /internalmedicinenews/article/241779/atopic-dermatitis/1-15-patients-who-start-dupilumab-may-develop
  • /pediatricnews/article/241779/atopic-dermatitis/1-15-patients-who-start-dupilumab-may-develop
  • /pediatrics/article/241779/atopic-dermatitis/1-15-patients-who-start-dupilumab-may-develop
  • /internalmedicine/article/241779/atopic-dermatitis/1-15-patients-who-start-dupilumab-may-develop
  • /dermatology/article/241779/atopic-dermatitis/1-15-patients-who-start-dupilumab-may-develop
  • /familymedicine/article/241779/atopic-dermatitis/1-15-patients-who-start-dupilumab-may-develop